Lyka Labs Limited (LYKALABS.NS)
INR 156.41
(1.68%)
INR 156.41
(1.68%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.75 INR | 83.59% |
| 2022 | -4.57 INR | -133.63% |
| 2021 | 13.59 INR | 486.08% |
| 2020 | -3.52 INR | 83.99% |
| 2019 | -21.98 INR | -1015.74% |
| 2018 | -1.97 INR | 70.55% |
| 2017 | -6.69 INR | -215.57% |
| 2016 | -2.12 INR | -225.44% |
| 2015 | 1.69 INR | 173.8% |
| 2014 | -2.29 INR | 25.16% |
| 2013 | -3.06 INR | -827.27% |
| 2012 | -0.33 INR | 0.0% |
| 2011 | - INR | -100.0% |
| 2010 | 1.07 INR | 137.41% |
| 2009 | -2.86 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.40 INR | 162.5% |
| 2023 Q2 | -0.15 INR | 73.68% |
| 2023 FY | - INR | 83.59% |
| 2023 Q3 | 0.54 INR | 460.0% |
| 2023 Q1 | -0.57 INR | 41.84% |
| 2023 Q4 | -0.64 INR | -218.52% |
| 2022 Q3 | -3.67 INR | -2958.33% |
| 2022 Q2 | -0.12 INR | -157.14% |
| 2022 Q1 | 0.21 INR | 104.01% |
| 2022 FY | - INR | -133.63% |
| 2022 Q4 | -0.98 INR | 73.3% |
| 2021 Q3 | 2.11 INR | -78.69% |
| 2021 Q2 | 9.90 INR | 45.59% |
| 2021 Q1 | 6.80 INR | 1114.29% |
| 2021 FY | - INR | 486.08% |
| 2021 Q4 | -5.24 INR | -348.34% |
| 2020 Q2 | -2.01 INR | -22.56% |
| 2020 FY | - INR | 83.99% |
| 2020 Q3 | -0.80 INR | 60.2% |
| 2020 Q4 | 0.56 INR | 170.0% |
| 2020 Q1 | -1.64 INR | 63.88% |
| 2019 Q4 | -4.54 INR | 68.69% |
| 2019 Q1 | -1.13 INR | -141.54% |
| 2019 FY | - INR | -1015.74% |
| 2019 Q2 | -1.14 INR | -0.88% |
| 2019 Q3 | -14.50 INR | -1171.93% |
| 2018 Q2 | -2.30 INR | -28.49% |
| 2018 Q4 | 2.72 INR | 354.21% |
| 2018 FY | - INR | 70.55% |
| 2018 Q1 | -1.79 INR | 0.0% |
| 2018 Q3 | -1.07 INR | 53.48% |
| 2017 FY | - INR | -215.57% |
| 2016 Q1 | -1.89 INR | 60.21% |
| 2016 FY | - INR | -225.44% |
| 2016 Q4 | 0.82 INR | 162.12% |
| 2016 Q3 | -1.32 INR | -728.57% |
| 2016 Q2 | 0.21 INR | 111.11% |
| 2015 Q2 | 6.26 INR | 712.99% |
| 2015 Q4 | -4.75 INR | -2165.22% |
| 2015 Q3 | 0.23 INR | -96.33% |
| 2015 Q1 | 0.77 INR | 153.1% |
| 2015 FY | - INR | 173.8% |
| 2014 Q2 | 2.93 INR | 168.14% |
| 2014 Q1 | -4.30 INR | 0.0% |
| 2014 Q4 | -1.45 INR | 47.08% |
| 2014 Q3 | -2.74 INR | -193.52% |
| 2014 FY | - INR | 25.16% |
| 2013 Q3 | -4.42 INR | -215.71% |
| 2013 FY | - INR | -827.27% |
| 2013 Q1 | -1.14 INR | 56.15% |
| 2013 Q2 | -1.40 INR | -22.81% |
| 2012 Q2 | 0.19 INR | -77.65% |
| 2012 Q4 | -2.60 INR | -204.42% |
| 2012 Q3 | 2.49 INR | 1210.53% |
| 2012 FY | - INR | 0.0% |
| 2012 Q1 | 0.85 INR | 0.0% |
| 2011 FY | - INR | -100.0% |
| 2011 Q3 | -1.07 INR | 0.0% |
| 2010 FY | - INR | 137.41% |
| 2009 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biocon Limited | 8.55 INR | 108.772% |
| Blue Jet Healthcare Limited | 9.44 INR | 107.945% |
| Concord Biotech Limited | 29.45 INR | 102.547% |
| Dishman Carbogen Amcis Limited | -9.79 INR | 92.339% |
| Jubilant Ingrevia Limited | 11.56 INR | 106.488% |
| Panacea Biotec Limited | -0.19 INR | -294.737% |
| Piramal Pharma Limited | 0.14 INR | 635.714% |
| SMS Lifesciences India Limited | 30.08 INR | 102.493% |
| Supriya Lifescience Limited | 14.80 INR | 105.068% |
| Syngene International Limited | 12.71 INR | 105.901% |
| TAKE Solutions Limited | -8.18 INR | 90.831% |
| Zota Health Care Limited | -5.55 INR | 86.486% |